PLP
ATRS

Pleasant Lake Partners’s Antares Pharma, Inc. ATRS Stock Holding History

Pleasant Lake Partners’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-343,769
Closed -$578K – 5
2016
Q3 		$578K Sell
343,769
-658,185
-66% -$806K 0.84% 6
2016
Q2 		$1.05M Buy
+1,001,954
New +$968K 1.42% 8

Other funds holding ATRS

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pleasant Lake Partners's ATRS Position: Q4 2016 in Review

Pleasant Lake Partners sold out of Antares Pharma, Inc. (ATRS) in Q4 2016, closing a stake of 343,769 shares — an estimated $578K sold.

Pleasant Lake Partners first reported a position in ATRS in Q2 2016 and held it in 2 quarters. The position peaked at $1.05M in Q2 2016. 71 funds tracked by Wall St. Rank hold ATRS as of Q4 2016.

  • Pleasant Lake Partners reported no remaining Antares Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
  • Pleasant Lake Partners sold 343,769 Antares Pharma, Inc. shares in Q4 2016, an estimated $578K.
  • Pleasant Lake Partners first reported a position in Antares Pharma, Inc. in Q2 2016 and held it in 2 quarters.
  • Pleasant Lake Partners's Antares Pharma, Inc. position peaked at $1.05M in Q2 2016.
  • 71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2016.

Based on Pleasant Lake Partners's 13F filing for Q4 2016, filed 14 Feb 2017.